Prolonged survival of B-lineage acute lymphoblastic leukemia cells is accompanied by overexpression of bcl-2 protein.
暂无分享,去创建一个
F. Behm | S. Raimondi | D. Campana | C. Pui | E. Coustan-Smith | R. Ashmun | M. Buschle | M. Aricò | A. Manabe | A. Biondi | Dario Campana | S. C. Raimondi | Atsushi Manabe | Maurizio Aricò
[1] F. Behm,et al. Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. , 1992, Blood.
[2] S. Jhanwar,et al. Distinct patterns of chromosome abnormalities characterize childhood non‐Hodgkin's lymphoma , 1992, British journal of haematology.
[3] V. Fadok,et al. Apoptosis and programmed cell death in immunity. , 1992, Annual review of immunology.
[4] S. Korsmeyer,et al. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes , 1991, Cell.
[5] T. Lebien,et al. Development of a bone marrow culture for maintenance and growth of normal human B cell precursors. , 1991, Journal of immunology.
[6] J. Banchereau,et al. Interleukin-7 induces the proliferation of normal human B-cell precursors , 1991 .
[7] A. Rolink,et al. Molecular and cellular origins of B lymphocyte diversity , 1991, Cell.
[8] C. Abboud,et al. Vascular cell adhesion molecule-1 and the integrin VLA-4 mediate adhesion of human B cell precursors to cultured bone marrow adherent cells. , 1991, The Journal of clinical investigation.
[9] S. Korsmeyer,et al. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[10] I. Maclennan,et al. Germinal center cells express bcl‐2 protein after activation by signals which prevent their entry into apoptosis , 1991, European journal of immunology.
[11] Gwyn T. Williams. Programmed cell death: Apoptosis and oncogenesis , 1991, Cell.
[12] Christopher T Denny,et al. Leukemia and the disruption of normal hematopoiesis , 1991, Cell.
[13] T. McDonnell,et al. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18) , 1991, Nature.
[14] J. Giorgi,et al. A gentle fixation and permeabilization method for combined cell surface and intracellular staining with improved precision in DNA quantification. , 1991, Cytometry.
[15] D. Mason,et al. Bcl-2 protein expression in follicular lymphomas in absence of 14;18 translocation , 1990, The Lancet.
[16] R. Schreiber,et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death , 1990, Nature.
[17] D. G. Osmond,et al. Microenvironmental organization and stromal cell associations of B lymphocyte precursor cells in mouse bone marrow , 1990, European journal of immunology.
[18] A. Boyd,et al. Cloned stromal cell lines derived from human Whitlock/Witte-type long-term bone marrow cultures. , 1990, Experimental hematology.
[19] D. Mason,et al. Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. , 1990, The American journal of pathology.
[20] S. Korsmeyer,et al. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. , 1990, Journal of immunology.
[21] M. Koury,et al. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. , 1990, Science.
[22] T. Dexter,et al. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis , 1990, Nature.
[23] I. Maclennan,et al. Mechanism of antigen-driven selection in germinal centres , 1989, Nature.
[24] F. Alt,et al. Molecular characterization of the lymphoid V(D)J recombination activity. , 1989, The Journal of biological chemistry.
[25] M. Lavin,et al. Cell death by apoptosis in acute leukaemia , 1989, The Journal of pathology.
[26] D. Campana,et al. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases. , 1989, Leukemia.
[27] P. Nowell,et al. Oncogenic potential of bcl-2 demonstrated by gene transfer , 1988, Nature.
[28] David L. Vaux,et al. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.
[29] A. Carroll,et al. Bone marrow origin of a B-cell lymphoma , 1988 .
[30] D. Campana,et al. Proliferation of normal and malignant human immature lymphoid cells , 1988 .
[31] A. Carroll,et al. Bone marrow origin of a B-cell lymphoma. , 1988, Blood.
[32] S. Korsmeyer,et al. Mechanism of the t(14;18) chromosomal translocation: structural analysis of both derivative 14 and 18 reciprocal partners. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[33] M. Greaves. Differentiation-linked leukemogenesis in lymphocytes. , 1986, Science.
[34] J. Sklar,et al. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation , 1986, Cell.
[35] Y. Tsujimoto,et al. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[36] Y. Tsujimoto,et al. Involvement of the bcl-2 gene in human follicular lymphoma. , 1985, Science.
[37] M. Oken,et al. Recurrent chromosomal defects are found in most patients with non-Hodgkin's-lymphoma. , 1984, Cancer genetics and cytogenetics.
[38] K A Muirhead,et al. Determination of linear fluorescence intensities from flow cytometric data accumulated with logarithmic amplifiers. , 1983, Cytometry.
[39] W. Knapp,et al. Anatomical distribution of call antigen expressing cells in normal lymphatic tissue and in lymphomas. , 1982, Leukemia research.